MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 188 filers reported holding MEDIVATION INC in Q2 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $38,026,000 | +1543.3% | 630,613 | +1153.3% | 0.17% | +1230.8% |
| Q1 2016 | $2,314,000 | +304.5% | 50,318 | +324.9% | 0.01% | +333.3% |
| Q4 2015 | $572,000 | -30.9% | 11,842 | +63.3% | 0.00% | -25.0% |
| Q2 2015 | $828,000 | +69.0% | 7,253 | +90.9% | 0.00% | +33.3% |
| Q1 2015 | $490,000 | -74.1% | 3,800 | -80.0% | 0.00% | -72.7% |
| Q4 2014 | $1,893,000 | +32.4% | 19,000 | +31.4% | 0.01% | +10.0% |
| Q3 2014 | $1,430,000 | -41.7% | 14,461 | -62.1% | 0.01% | -58.3% |
| Q1 2014 | $2,453,000 | +24.0% | 38,112 | +23.0% | 0.02% | +84.6% |
| Q4 2013 | $1,978,000 | -34.2% | 30,995 | -38.2% | 0.01% | -55.2% |
| Q3 2013 | $3,006,000 | +37.1% | 50,147 | +12.5% | 0.03% | +20.8% |
| Q2 2013 | $2,192,000 | – | 44,560 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |